Experimental countermeasures against Ebola virus: current progress and an ethical conundrum

FA Plummer, G Wong, GP Kobinger - CMAJ, 2014 - Can Med Assoc
1130 CMAJ, October 21, 2014, 186 (15) put their lives on the line to help Liberians during an
uncontrolled, unprecedented outbreak, or two of the hundreds of Africans who might benefit …

[PDF][PDF] Ethical considerations for use of unregistered interventions for Ebola viral disease: reportof anadvisory panel to WHO

World Health Organization - 2014 - apps.who.int
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus
disease in history. Previous Ebola outbreaks have been contained by existing interventions …

Antibody therapy as a future treatment option for Ebola virus infection

K Matsuno, A Takada - 2007 - Future Medicine
Ebola virus causes lethal hemorrhagic fever in human and nonhuman primates. Effective
prophylaxis and treatment for this disease are not yet available. Antisera and monoclonal …

[PDF][PDF] How the current West African Ebola epidemic is altering views on the need for vaccines and is galvanizing a global effort to field test leading candidates

MM Levine, M Tapia, AV Hill, SO Sow - Journal of Infectious …, 2014 - academia.edu
Since it first appeared as a clinical syndrome in Central Africa in the mid-1970s
accompanied by isolation of the causative virus, Ebolavirus disease has fascinated …

Ebolavirus in West Africa, and the use of experimental therapies or vaccines

T Hoenen, H Feldmann - BMC biology, 2014 - Springer
Response to the current ebolavirus outbreak based on traditional control measures has so
far been insufficient to prevent the virus from spreading rapidly. This has led to urgent …

A race for an Ebola vaccine: promises and obstacles

CL Cooper, S Bavari - Trends in microbiology, 2015 - cell.com
While several impeding factors have limited Ebola vaccine development, the current
epidemic has provided a surge which may lead to a record pace for a vaccine against Ebola …

DR Congo: investigational research against Ebola virus

A Green - The Lancet, 2018 - thelancet.com
With one investigational vaccine al ready deployed, officials are discussing the possibility of
introducing as many as six other preventive and therapeutic interventions in the midst of the …

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

NJ Sullivan, JE Martin, BS Graham… - Nature reviews …, 2009 - nature.com
Ebola virus infection is a highly lethal disease for which there are no effective therapeutic or
preventive treatments. Several vaccines have provided immune protection in laboratory …

A review of phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?

T Lambe, G Bowyer, KJ Ewer - … Transactions of the …, 2017 - royalsocietypublishing.org
Sporadic outbreaks of Ebola virus infection have been documented since the mid-Seventies
and viral exposure can lead to lethal haemorrhagic fever with case fatalities as high as 90 …

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

D Corti, J Misasi, S Mulangu, DA Stanley, M Kanekiyo… - Science, 2016 - science.org
Ebola virus disease in humans is highly lethal, with case fatality rates ranging from 25 to
90%. There is no licensed treatment or vaccine against the virus, underscoring the need for …